Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Idarubicin
Drug ID BADD_D01127
Description An orally administered anthracycline antineoplastic. The compound has shown activity against breast cancer, lymphomas and leukemias, together with the potential for reduced cardiac toxicity.
Indications and Usage For the treatment of acute myeloid leukemia (AML) in adults. This includes French-American-British (FAB) classifications M1 through M7.
Marketing Status Prescription; Discontinued
ATC Code L01DB06
DrugBank ID DB01177
KEGG ID D08062
MeSH ID D015255
PubChem ID 42890
TTD Drug ID D01XDL
NDC Product Code Not Available
Synonyms Idarubicin | 4-Desmethoxydaunorubicin | 4 Desmethoxydaunorubicin | 4-Demethoxydaunorubicin | 4 Demethoxydaunorubicin | IMI-30 | IMI 30 | IMI30 | NSC-256439 | NSC 256439 | NSC256439 | Idarubicin Hydrochloride | Hydrochloride, Idarubicin
Chemical Information
Molecular Formula C26H27NO9
CAS Registry Number 58957-92-9
SMILES CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hepatic function abnormal09.01.02.001--Not Available
Hypersensitivity10.01.03.003--
Hyperuricaemia14.09.01.003--
Immune system disorder10.02.01.001--Not Available
Infection11.01.08.002--Not Available
Injection site urticaria23.04.02.003; 12.07.03.029; 10.01.06.003; 08.02.03.029--Not Available
Leukaemia16.01.03.001; 01.10.03.001--
Leukopenia01.02.02.001--Not Available
Local reaction08.01.03.012--Not Available
Lymphoma16.20.01.001; 01.12.01.001--Not Available
Menopausal symptoms21.02.02.002--Not Available
Mucosal inflammation08.01.06.002--Not Available
Myelodysplastic syndrome01.10.04.001; 16.01.04.001--
Myocardial infarction24.04.04.009; 02.02.02.007--
Myocarditis02.04.03.001--
Nausea07.01.07.001--
Necrosis24.04.02.006; 08.03.03.001--Not Available
Neoplasm16.16.02.001--Not Available
Neutropenia01.02.03.004--Not Available
Non-Hodgkin's lymphoma16.35.01.001; 01.17.01.001--Not Available
Oesophagitis07.08.05.001--
Palmar-plantar erythrodysaesthesia syndrome23.07.04.001; 17.02.07.009--
Pancytopenia01.03.03.003--Not Available
Pericarditis02.06.02.001--
Phlebitis24.05.03.001; 12.02.01.002--
Radiation injury12.05.02.003--Not Available
Rash23.03.13.001--Not Available
Rash generalised23.03.13.002--Not Available
Seizure17.12.03.001--
Sepsis11.01.11.003--
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages